Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Neeland, MR, Bannister, S, Clifford, V, Dohle, K, Mulholland, K, Sutton, P, Curtis, N, Steer, AC, Burgner, DP, Crawford, NW, et al.
Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children..
Nat Commun
12(1)
:
1084
2021
view publication
Thorsen, SU, Collier, F, Pezic, A, O'Hely, M, Clarke, M, Tang, MLK, Burgner, D, Vuillermin, P, Ponsonby, A-L, Barwon Infant Study Investigator Group.
Maternal and Cord Blood 25-Hydroxyvitamin D3 Are Associated with Increased Cord Blood and Naive and Activated Regulatory T Cells: The Barwon Infant Study..
J Immunol
206(4)
:
874 -882
2021
view publication
Andraos, S, Lange, K, Clifford, SA, Jones, B, Thorstensen, EB, Wake, M, Burgner, DP, Saffery, R, O'Sullivan, JM.
Population epidemiology and concordance for plasma amino acids and precursors in 11-12-year-old children and their parents..
Sci Rep
11(1)
:
3619
2021
view publication
Rowland, R, Sass, Z, Ponsonby, A-L, Pezic, A, Tang, ML, Vuillermin, P, Gray, L, Burgner, D, Barwon Infant Study Investigator Group.
Burden of infection in Australian infants..
J Paediatr Child Health
57(2)
:
204 -211
2021
view publication
Matricciani, L, Dumuid, D, Paquet, C, Fraysse, F, Wang, Y, Baur, LA, Juonala, M, Ranganathan, S, Lycett, K, Kerr, JA, et al.
Sleep and cardiometabolic health in children and adults: examining sleep as a component of the 24-h day..
Sleep Med
78:
63 -74
2021
view publication